Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

While multiple-sclerosis patients have waited years for pills to be developed to treat the...

  • Tuesday, November 20, 2012, 9:40 AM ET
    While multiple-sclerosis patients have waited years for pills to be developed to treat the debilitating disease, doctors are warning them to be wary. That's because drugs such as Novartis' (NVS) Gilenya and Sanofi's (SNY) Aubagio can have significant side-effects. All of which is positive for Teva (TEVA), whose Copaxone is injected rather than taken orally.
Track new comments on this story

This news story has 4 comments:

  •  
    And yet the ongoing threats of full scale war in the Middle East seem to trump any good news there and the stock goes nowhere.
    20 Nov 2012, 10:01 AM Reply Like
  •  
    you should be happy the stock is down.....buy more....
    20 Nov 2012, 10:02 AM Reply Like
  •  
    Teva is the most under valued stock in the world, nw they will get a currency boost and there plants have very little exposure to gaza.
    20 Nov 2012, 11:01 AM Reply Like
  •  
    it is by no means the most undervalued.....but it is cheap....long TEVA
    20 Nov 2012, 12:31 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »